Fig. 1From: A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumorsPlasma concentration-time profiles of a CPT-11 and b SN-38 at different PEP02 dosesBack to article page